| Literature DB >> 30202233 |
Ghaferah H Al-Hazmi1, Amani S Awaad2, Monerah R Alothman3, Saleh I Alqasoumi4.
Abstract
The phytochemical screening of Cyperus conglomeratus showed that carbohydrates and/or glycosides, flavonoids, tannins, sterols and/or triterpenes, and proteins and/or amino acids are present. The fatty acid profile comprised major; palmitic, oleic, heptadecanoic, linoleic and minor; arachidonic, lignoceric, stearic, and myristic acid. Two compounds; namely, α-amyrin and β-sitosterol were isolated by the fractionation of unsaponifiable matter. The acute toxicity study showed that the reported after oral administration of the alcohol extract (TAE) showed that the plant was highly safe as the LD50 was more than 4000 mg/kg. These results were well supported by the sub-chronic toxicity, as the TAE administrated to rats for 15 consecutive days at dose 1000 mg/kg showed no alteration in the liver and kidney functions. Moreover, the extract of the plant exhibited anti-candidal activity against different Candida species. The most potent activity, (23.1 ± 2.1, 0.98 µg/ml) and (22.3 ± 0.53, 0.98 µg/ml), was obtained by the chloroform and total extract, respectively against Candida albicans.Entities:
Keywords: Antimicrobial activity; Cyperus conglomeratus; Fatty acids; Phytochemical screening; α-amyrin; β-sitosterol
Year: 2018 PMID: 30202233 PMCID: PMC6128720 DOI: 10.1016/j.jsps.2018.03.007
Source DB: PubMed Journal: Saudi Pharm J ISSN: 1319-0164 Impact factor: 4.330
The GLC analysis of fatty acid methyl esters of Cyperus conglomeratus saponifiable matter.
| Peak number | Rt (min) | RRt | No. C | Authentic methyl ester of | Percentage |
|---|---|---|---|---|---|
| 1 | 6.40 | 0.33 | 10:0 | Capric acid | 0.04 |
| 2 | 11.58 | 0.60 | 12:0 | Lauric acid | 0.34 |
| 3 | 12.27 | 0.64 | 13:0 | Tridecanoic acid | 0.69 |
| 4 | 13.35 | 0.69 | 14:0 | Tetradecanoic acid | 2.76 |
| 5 | 14.02 | 0.73 | 14:0 | Myristic acid | 23.60 |
| 6 | 15.02 | 0.78 | 14:1 | Myristiolic acid | 5.87 |
| 7 | 15.88 | 0.83 | 16:0 | Palmitic acid | 2.87 |
| 8 | 18.12 | 0.94 | 16:1 | Palmitolic acid | 14.36 |
| 9 | 19.23 | 1.00 | 18:0 | Steric acid | 33.05 |
| 10 | 20.23 | 1.05 | 18:1 | Oleic acid | 0.37 |
| 11 | 21.13 | 1.09 | 18:2 | Linoleic acid | 3.91 |
| 12 | 26.80 | 1.39 | 20:4 | Arachidonic acid | 0.20 |
| 13 | 29.37 | 1.53 | 22:6 | Henatriacontanoic acid | 0.68 |
| 14 | 37.05 | 1.93 | 22:0 | Behenoic acid | 10.89 |
Rt: retention time, RRt: relative retention time, No. C: number of carbon.
1H NMR chemical shift assignments of C1.
| Proton no. | Chemical shift ppm | Proton no. | Chemical shift ppm |
|---|---|---|---|
| H-12 | 5.60(1H,t, | H-25 | 1.12(3H,s) |
| —OH | 3.45(1H,s) | H-6&H-7 | 1.03(4H,q, |
| H-3 | 2.07(1H, | H-15&H-16 | 0.99(4H,t, |
| H-1&H-2 | 1.81(4H,m) | H-26 | 0.90(3H,s) |
| H-23&H-24 | 1.59(6H,m) | H-19&H-21 | 0.88(4H,s) |
| H-29&H-30 | 1.48(6H,m) | H-22 | 0.86(2H,s) |
| H-5 | 1.3(1H,s) | H-27 | 0.81(3H,d, |
| H-9 | 1.23(1H,S, | H-28 | 0.76(3H,s) |
| H-11 | 1.17(2H,m) | – | – |
13C NMR chemical shift assignments of C2.
| Carbon no. | Chemical shift ppm | Carbon no. | Chemical shift ppm |
|---|---|---|---|
| 7 | 121.86 | 9 | 29.23 |
| 3 | 71.93 | 16 | 28.38 |
| 17 | 56.87 | 5 | 24.43 |
| 14 | 56.14 | 11 | 22.08 |
| 21 | 50.23 | 15 | 23.16 |
| 22 | 45.93 | 27 | 21.20 |
| 19 | 42.42 | 23 | 19.96 |
| 4 | 39.88 | 24 | 19.53 |
| 12 | 37.36 | 25 | 19.13 |
| 2 | 36.62 | 29&30 | 18.90 |
| 18 | 36.27 | 26 | 12.10 |
| 20 | 34.04 | 28 | 11.98 |
| 1 | 32.03 | ||
| 8 | 32.01 |
Fig. 1The isolated compounds from Cyperus conglomeratus Rottb.
Effect of Cyperus conglomeratus Rottb on liver and kidney functions.
| Treatment | Liver function (U/l) | Kidney function (mg/dl) | ||
|---|---|---|---|---|
| AST | ALT | Blood urea | Serum Creatinine | |
| Control | 65.11 ± 2.62 | 144.62 ± 5.39 | 32.16 ± 1.83 | 0.36 ± 0.03 |
| Alcohol extract (500 mg/kg) | 67.39 ± 4.26 | 146.50 ± 4.27 | 33.40 ± 1.96 | 0.37 ± 0.03 |
The anticandidal activity of Cyperus conglomeratus extract and isolated compounds.
| Candida species | ||||||
|---|---|---|---|---|---|---|
| Diameter of inhibition zone (mm) | Total extract | 22 | 11 | 18 | 13 | 15 |
| Chloroform extract | 23 | 16 | 20 | 15 | 17 | |
| Comp. C1 | 18 | 14 | – | 14 | – | |
| Comp. C2 | – | – | 19 | 11 | 8 | |
| Amphotericin B | 26 | 24 | 21 | 18 | 20 | |
| Minimum Inhibitory Concentration (MIC) (µg/ml) | Total extract | 3.9 | – | 125 | – | – |
| Chloroform extract | 3.9 | 125 | 15.6 | – | 125 | |
| Comp. S1 | 250 | – | – | – | – | |
| Comp. S2 | – | – | 250 | – | – | |
| Amphotericin B | 0.12 | 0.12 | 0.24 | 0.48 | 0.24 | |